Drug intelligence / Profile preview

low molecular weight fucosan sulfate

Development stage
Unknown
Lead developer
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Low molecular weight fucosan sulfate (LMWFS) is a depolymerized sulfated polysaccharide derived from brown algae, currently under clinical investigation as an adjunctive therapy for type 2 diabetes mellitus and prediabetes. Developed by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, LMWFS is designed to regulate blood glucose levels through multiple mechanisms, including the inhibition of alpha-glucosidase and alpha-amylase to delay carbohydrate digestion, and the inhibition of protein-tyrosine phosphatase 1B (PTP1B) to enhance insulin sensitivity. Early-stage clinical trials (Phase 0) in China are evaluating its safety and efficacy in reducing postprandial hyperglycemia and improving overall glycemic control when used alongside standard treatments.

Other names
LMWFS
02

Targets

F (Coagulation factors)PTPN1 (Protein tyrosine phosphatase 1B)Sucrase-Isomaltase

Beyond the preview

Go deeper on low molecular weight fucosan sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on low molecular weight fucosan sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call